Composition for treatment of articular cartilage damage

Details Composition for treatment of articular cartilage damage Composition for treatment of articular cartilage damage

2002-08-14

2008-12-02

Barnhart, Lora E (Department: 1651)

Chemistry: molecular biology and microbiology

Animal cell, per se ; composition thereof; process of...

C424S093100, C424S422000

Reexamination Certificate

active

07459307

ABSTRACT:
Disclosed herein is a composition for the treatment of articular cartilage damage or loss or defect. The composition for the treatment of articular cartilage injury of the present invention includes (i) cellular components separated, proliferated, and/or differentiated from the umbilical cord blood, (ii) a culture medium; and (iii) a biocompatible polymer. The composition has very superior ability of proliferation and differentiation and easier to be collected and acquired.

REFERENCES:
patent: 5902741 (1999-05-01), Purchio et al.
patent: 5906934 (1999-05-01), Grande et al.
patent: 1099754 (2001-05-01), None
patent: 98/51317 (1998-11-01), None
Radice M et al. 2000. Hyaluronan-based biopolymers as delivery for bone marrow-derived mesenchymal progenitors. J Biomed Mater Res 50: 101-109.
Alejandro et al., “Mesenchymal progenitor cells in human umbilical cord blood”, British Journal of Haematology, Oxford, GB, vol. 109, No. 1, Apr. 2000, pp. 235-242.
Wu Chengru et al., China Journal Surgery, Feb. 2001, vol. 39, No. 2, pp. 144-147 (indicated in Office Action as vol. 29).
Caplan et al., “Principles of cartilage repair and regeneration”, Clinical Orthopaedics and Related Research, Sep. 1997, No. 342, pp. 254-269.
M.F. Pittenger et al., Science, vol. 284, Apr. 2, 1999, pp. 143-147.
H.M. Lazarus et al., Bone Marrow Transplantation, 1995, vol. 16, pp. 557-564.
F. Barry et al., Experimental Cell Research, 2001, vol. 268, pp. 189-200.
N. Jaiswal et al., Journal of Cellular Biochemistry, 1997, vol. 64, pp. 295-312.
S. Nehrer et al., Biomaterials, 1998, vol. 19, pp. 2313-2328.
P.L. Fitzpatrick et al., Aust. N.Z. J. Surg., 1998, vol. 68, pp. 573-579.
Cesare Campagnoli et al., “Identification of Mesenchymal Stem/Progenitor Cells in Human First-Trimester Fetal Blood, Liver, and Bone Marrow”, Hematopoiesis, Blood, Oct. 15, 2001, vol. 98, No. 8, pp. 2396-2402.
Sarah A. Wexler et al., “Adult Bone Marrow Is A Rich Source of Human Mesenchymal ‘Stem’ Cells But Umbilical Cord and Mobilized Adult Blood Are Not”, British Journal of Haematology, 2003 Blackwell Publishing Ltd., vol. 121, pp. 368-374.
Sekiya, I., et al., “In vitro cartilage formation by human adult stem cells from bone marrow stroma defines the sequence of cellular and molecular events during chondrogenesis,” PNAS, 99:7, 4397-4402, Apr. 2, 2002.
Sekiya, I., et al., “Expansion of Human Adult Stem Cells from Bone Marrow Stroma: Conditions that Maximize the Yields for Early Progentiors and Evaluate Their Quality,” Stem Cells, 20, 530-541, 2002.
Indrawattana, N., et al., “Growth factor combination for chondrogenic induction from human mescenchymal stem cell,” Biochem. and Biophy. Research Comm., 320, 914-919, 2004.
Radice, M. et al., “Hyaluronan-based biopolymers as delivery vehicles for bone-marrow-derived mesenchymal progenitors,” Institute of Histology and Embryology, Univ. of Padova, Padova, Italy, Clinic of Orthopedic and Trauma Surgery, Univ. of Padova, Padova, Italy, accepted Aug. 4, 1999; pp. 101-109.
Grande, D.A., et al., “Repair of Articular Cartilage Defects Using Mesenchymal Stem Cells,” Tissue Engineering, vol. 1, No. 4, 1995, pp. 345-353.
Elisseeff, J., et al., “Transdermal photopolymerization for minimally invasive implantation,” Proc. Natl. Acad. Sci. USA, vol. 96, Mar. 1999, pp. 3104-3107.
Saim, A.B., et al., “Engineering Autogenous Cartilage in the Shape of a Helix Using an Injectable Hydrogel Scaffold,” The Laryngoscope, 110, Oct. 2000, pp. 1694-1697.
Grande, D.A., et al., “Cartilage Tissue Engineering: Current Limitations and Solutions,” Clinical Orthopaedics and Related Research, No. 367S, 1999, pp. S176-S185.
Von der Mark, K., et al., “Relationship between cell shape and type of collagen synthesised as chondrocytes lose their cartilage phenotype in culture,” Nature, vol. 267, Jun. 9, 1977, 531-532.
Benya, P.D., et al., “Dedifferentiated Chondrocytes Reexpress the Differentiated Collagen Phenotype When Cultured in Agarose Gels,” Cell, vol. 30, Aug. 1982, pp. 215-224.

Affiliated with

Also associated with

Rating

Composition for treatment of articular cartilage damage does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Composition for treatment of articular cartilage damage, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Composition for treatment of articular cartilage damage will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4025384